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Fast and Efficient Differentiation of
Mouse Embryonic Stem Cells Into
ATP-Responsive Astrocytes
Deppo S. Juneja, Slawomir Nasuto and Evangelos Delivopoulos*
School of Biological Sciences, University of Reading, Reading, United Kingdom
Astrocytes are multifunctional cells in the CNS, involved in the regulation
of neurovascular coupling, the modulation of electrolytes, and the cycling of
neurotransmitters at synapses. Induction of astrocytes from stem cells remains a
largely underdeveloped area, as current protocols are time consuming, lack granularity
in astrocytic subtype generation, and often are not as efficient as neural induction
methods. In this paper we present an efficient method to differentiate astrocytes
from mouse embryonic stem cells. Our technique uses a cell suspension protocol
to produce embryoid bodies (EBs) that are neurally inducted and seeded onto
laminin coated surfaces. Plated EBs attach to the surface and release migrating
cells to their surrounding environment, which are further inducted into the astrocytic
lineage, through an optimized, heparin-based media. Characterization and functional
assessment of the cells consists of immunofluorescent labeling for specific astrocytic
proteins and sensitivity to adenosine triphosphate (ATP) stimulation. Our experimental
results show that even at the earliest stages of the protocol, cells are positive for
astrocytic markers (GFAP, ALDH1L1, S100β, and GLAST) with variant expression
patterns and purinergic receptors (P2Y). Generated astrocytes also exhibit differential
Ca2+ transients upon stimulation with ATP, which evolve over the differentiation period.
Metabotropic purinoceptors P2Y1R are expressed and we offer preliminary evidence
that metabotropic purinoceptors contribute to Ca2+ transients. Our protocol is simple,
efficient and fast, facilitating its use in multiple investigations, particularly in vitro studies
of engineered neural networks.
Keywords: stem cell, purinergic, adenosine triphosphate, GFAP, S100β, astrocyte
INTRODUCTION
Astrocytes are present in the nervous system in approximately equal numbers to neurons and have
multifunctional physical connections with synapses, other astrocytes and blood vessels (Lent et al.,
2012). In the last 20 years, numerous investigations have revealed associations between neurological
disorders and astrocytic malfunction. For example, loss of dopaminergic neurons in Parkinson’s
disease is linked to abnormal accumulation of α-synuclein by both neurons and astrocytes (Lee
et al., 2010). In a Huntington’s disease mouse model, an astrocytic ion channel deficit (Kir4.1) was
revealed to be both the cause of medium spiny neuron dysfunction and a therapeutic target (Tong
et al., 2016). As a result of such findings and the recent demonstration of transplanted astrocyte
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reprograming into functional neurons (Zhang L. et al.,
2015), astrocytes are now seen as principal candidates for
transplantation studies and cell replacement therapy (Zhang Y.
et al., 2016). It is now accepted, that astrocytes participate in
information processing in the brain, even enhancing synaptic
plasticity and learning in cross species transplantations (Han
et al., 2013). Therefore, the efficient derivation of functional
astrocytes from differentiating stem cells is rapidly becoming
the focus of many research labs, as it is seen as a crucial
step in understanding brain function in health and disease.
Furthermore, from a neuroengineering perspective, facilitation
of astrocyte procurement enables multiple studies, investigating
neural circuit patterning (Delivopoulos et al., 2009; Delivopoulos
and Murray, 2011; Unsworth et al., 2011; Raos et al., 2018), and
development (Clarke and Barres, 2013) both in vitro and in vivo.
Differentiation of astrocytes from pluripotent stem cells
has gained considerable momentum in the past decade.
Proposed methods use embryoid bodies (EBs) of human induced
pluripotent stem cells (hIPSCs) to generate glial progenitor
cells (GPC) (Santos et al., 2017), neural progenitor cells (NPC)
(Tcw et al., 2017), or neuroepithelial cells (Krencik et al.,
2011), which are then induced into human astrocytes. Murine
astrocytes have been generated from reprogramed fibroblasts
via small molecules (Tian et al., 2016) and also from NPC
with the use of BMP4 (Kleiderman et al., 2016). A two-step
differentiation scheme was employed by Kuegler et al. (2012)
to derive functional murine astrocytes from the CGR8 mouse
embryonic stem cell line (mESC). Recently, Tiwari et al. (2018)
illustrated that ATF3 and NFIA transcription factors drive
astrocyte differentiation from mESC, while RUNTX2 promotes
astrocyte maturation. Nonetheless, the majority of current
protocols require a considerable investment of time, before
producing functional astrocytes that express expected markers.
For example, a protocol by Krencik et al. that was based on basic
fibroblast growth factor (FGF2) and epidermal growth factor
(EGF) required 6 months of differentiation (Krencik and Zhang,
2011). Emdad et al. (2011) shortened astrocyte differentiation to
80 days, in a protocol requiring manual selection of rosettes on
the initial stage of differentiation (Emdad et al., 2011). Roybon
et al. (2013) generated both reactive and quiescent astrocytes
in a similar time frame (90 days) (Roybon et al., 2013), while
Zhou et al. (2016) presented an accelerated method for astrocyte
differentiation (28 days), based on floating neurospheres.
In glial biology, astrocytes were traditionally considered a
homogenous population of cells. This misconception was later
extended to astrocytes differentiated from stem cells. However,
recent studies have allowed a greater appreciation of the diverse
regional profiles and functional roles of primary astrocytes. For
example, functional heterogeneity of astrocytes within the glial
scar may have important implications during gliosis and CNS
regeneration (Adams and Gallo, 2018). This has been linked
to variant isoforms of GFAP (α, β, γ, δ, and κ), which are
expressed heterogeneously in both the healthy and pathological
CNS (Moeton et al., 2016; van Bodegraven et al., 2019). Equally,
region specific responses of astrocytes to neurotrophins (NGF,
BDNF) affect wound closure at lesion sites (Cragnolini et al.,
2018), while cellular and regional diversity of astrocytes is
related to differential transcriptomic changes, during multiple
sclerosis and potentially other neurodegenerative diseases (Itoh
et al., 2018). A possible basis for astrocyte heterogeneity may be
the spatiotemporal patterns of morphogens that emerge during
development of the mammalian CNS and diversify both glial and
neuronal progenitors (Ben Haim and Rowitch, 2017). Regardless
of origin, astrocyte diversity in gene expression, morphology
and function has been established, and appears essential in both
physiological and pathological conditions.
In this study, we derive functional astrocytes from mouse
embryonic stem cells, after only 13 days of differentiation. To
our knowledge, our protocol is currently the fastest (<2 weeks),
reproducible method to generate astrocytes from mESC. Our
technique employs a cell suspension protocol proposed by
Peljto et al. (2010) to produce EBs, which are neuralized via
retinoic acid treatment for 6 days. EBs are then plated on
laminin coated surfaces and cells resembling astrocytes start
migrating away from the seeded EBs, within 2 days in vitro.
We characterized migrating cells with different techniques at
7, 14, 21, and 28 DIV and our results demonstrate that
they express established astrocytic markers (GFAP, ALDH1L1,
S100β, and GLAST) associated to astrocytic development
and glutamate uptake. We offer evidence that the produced
population of astrocytes is heterogeneous, with cells exhibiting
different markers and transient Ca2+ responses upon adenosine
triphosphate (ATP) stimulation. These responses to ATP could
be due to metabotropic purinoceptor (P2Y1R) activation and the
downstream release of intracellular Ca2+ from stores.
MATERIALS AND METHODS
Maintenance of Mouse Embryonic Stem
Cell Line
The mouse embryonic stem cell (mESC) line CGR8 (derived
from Mus musculus, strain 129) were incubated at 37◦C, 5%
CO2, in gelatine coated flasks, in a media composed of DMEM,
supplemented with 10% fetal calf serum (FCS) (Gibco Industries,
Inc., Langley, OK, United States), 1% penicillin/streptomycin
Pen/Strep), 1% L-glutamine (Life Technologies, Paisley,
United Kingdom), 100 µM 2- Mercaptoethanol and LIF
(Leukemia Inhibitory Factor) (1000 units/mL) (Sigma Aldrich,
United Kingdom). Cells were passaged every 2 days, and assessed
daily for confluence.
Differentiation of Mouse Embryonic
Stem Cell Line Into Astrocytes
Maintenance cultures were used for differentiation at high
confluence (60–80%). The process of differentiation followed a
combination and adjustment of two different protocols from
Peljto et al. (2010) and Kuegler et al. (2012) as shown in Figure 1.
Briefly, 500,000 cells/ml were seeded onto low attachment petri
dishes, and suspended in 10 ml of ADFNK media (Advanced
DMEM/F-12:Neurobasal medium (1:1) supplemented with 10%
Knockout Serum Replacement, 1% L- Glutamine, 100 µM
β-mercaptoethanol, and 1% Pen/Strep), devoid of LIF. After
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FIGURE 1 | Schematic representation of the protocol used for the
differentiation of mouse embryonic stem cell lines (mESCs) into astrocytes
over a total time of 2–5 weeks. Mouse ESCs were used to generate embryoid
bodies (EBs), which were seeded onto laminated glass coverslips. Migrating
astrocytes were detected and labeled from DIV 7 to DIV 28.
2 days, single cells formed EBs. EB were exposed to fresh ADFNK
media containing 1 µM retinoic acid (RA) (Sigma Aldrich,
United Kingdom) at day 2. At day 5, RA was removed and fresh
ADFNK media was added. At day 6 an altered version of Kuegler
et al. (2012) protocol was utilized. Twenty to fifty intact EB were
seeded directly onto laminin coated 24 well plates containing
astrocyte differentiation media (ADMEM/F12, 2% FBS, N2, 1%
L-glutamine, 1% Pen/Strep, 100 µM β-mercaptoethanol and
50 µg/mL heparin (Robertson and Goldstein, 1988; Nagayasu
et al., 2005) (Sigma Aldrich, United Kingdom). The cells were
assessed via bright field microscopy every day and cultured for
up to 28 days. The media was changed every 2 days.
Immunofluorescence Labeling
Cells were washed with PBS, at 7, 14, 21, and 28 DIV, fixed with
3.7% formaldehyde in PBS for 30 minutes, and permeabilized
with 0.02% Triton X-100 diluted in 10% goat serum for
15 min. Subsequently, cells were washed with PBS and 10%
goat serum was added to block against non-specific binding
for 2 h. Cells were then stained with appropriate primary and
secondary antibodies (see Supplementary Table S1). Nuclei
were counterstained with H-33342 (Hoechst dye). Primary and
secondary antibodies were left on the fixed cultures for 2 h at
room temperature, or overnight at 4◦C.
Image Acquisition and Analysis,
Quantification of Marker Positive Cells,
and Co-localization
Images were acquired using an Axio Imager microscope (Zeiss,
Germany) and a Nikon A1-R confocal microscope with a
resonant scanner. Separate digital images (red 594 nm, green
488 nm, and blue 350 nm) of astrocyte stains and DNA (Hoechst
33342) were captured with a × 20 objective (1040× 1388 pixels)
from 3 non-overlapping microscopic fields per glass coverslip
(AxioCam CCD digital camera (Carl Zeiss). Focus was adjusted
for each new field, but fluorescent illumination and exposure
were kept constant to improve consistency during analysis.
Images were also collected with ×5 and ×10 objectives, from
wider fields of view. Scale bars were calibrated using AxioVision
software (release 4.6.3, Carl Zeiss).
Image analysis was performed in ImageJ (NIH – National
Institutes of Health) and MATLAB. For analysis of cell body
and nuclei, images were split into individual channels from RGB
(red 594 nm and green 488 nm, blue 350 nm) and thresholded
utilizing the Otsu method (Vala and Baxi, 2013) to remove any
uneven illumination. Any debris and unwanted artifacts were
cropped from the image. The original single channel image
was overlaid on top of the thresholded image and Pearson’s
correlation coefficient (PCC) analysis was performed to assess
their similarity. If PCC < 0.8 the image was thresholded
again, otherwise the image was analyzed for number of marker
positive cells and percentage area covered by marker positive
cells. Co-localization analysis was performed on co-labeled
cultures, using Pearson correlation coefficient analysis derived
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where R˜ and G˜ are the average intensities in the red and green
channels, respectively. Perfect positive (PCC = 1) and negative
(PCC = −1) correlations denote that the two markers are
expressed by either an individual or distinct cell populations,
respectively. A PCC of zero suggests the absence of any
relationship between the expressions of the two markers.
Calcium Spectrofluorometry
Astrocyte [Ca2+]i concentration dynamics were evaluated using
Ca2+ sensitive fluorescent dye Fluo-4/AM (Molecular Probes).
Cells were stimulated pharmacologically with ATP (Sigma
Aldrich, Poole, United Kingdom) at 50 uM concentration.
Prior to recording, cells loaded with Fluo-4/AM (2.5 µM) for
30 min at 37◦C, 5% CO2 (Molecular Probes) (Neary et al.,
1999; Gee et al., 2000; James and Butt, 2001). Subsequently,
cells were thoroughly rinsed three times, with Hank’s Balanced
Salt Solution (HBSS) to remove extracellular traces of the
dye and to complete de-esterification. In separate experiments
100 µM Suramin/10 µM MRS2179 was applied for 30 min
before imaging. In one culture, 10 µM of phospholipase C
(PLC) inhibitor U73122 was applied for 30 min prior to
imaging. All compounds were rinsed thoroughly three times
with HBSS before imaging. Excitation and emission wavelengths
were 494 nm and 516 nm, respectively. All fluorescence
measurements were made at 37◦C (Warner Instruments).
Changes in [Ca2+]i were detected with an inverted Nikon Eclipse
TE2000-S microscope (Nikon) equipped with a xenon arc lamp
(Sutter Instruments).
Calcium Spectrofluorometry Analysis
All data analysis was performed offline and data assessed
with Clampfit 10, WinFlour software packages (Strathclyde
University) and modified MATLAB algorithms. Astrocytes were
identified at 488 nm excitation, and cell bodies within a single
plane of focus were selected as regions of interest (ROI). Five
to ten ROI were simultaneously recorded from each glass
coverslip in each experiment. Three separate experiments were
performed. Fluorescence intensity was normalized by dividing
fluorescence at time t by the mean intensity between 0–20 s,
before addition of agonist (F/F0). Waveforms were filtered using
a low pass filter (Otsu et al., 2015) and the following parameters
characterizing them were estimated: rise time (RT) (time taken
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from 10% to 90% of peak amplitude), decay time constant tau
(exponential curve (f (t) = a∗exp(−t/tau)) was fit from peak
amplitude till the end of the experiment) and latency (time
taken from ATP application to initiation of a calcium transient)
(Kang and Othmer, 2009; Okada et al., 2012; Hashioka et al.,
2014). Waveforms were categorized as either monophasic or
biphasic, depending on whether the decay phase exhibited a
sustained response after the half-amplitude of peak response.
The end of the experiment was taken at 300 s or where the
error of the fitted exponential curve f (t) (see decay tau above)
to the actual waveform was equal or greater than 10% (if this
occurred earlier).
Statistical Analysis
Experiments with immunofluorescent labeling and Ca2+
imaging were performed in triplicates. In each of the three
experiments 3 glass coverslips for each timepoint (7, 14, 21, and
28 DIV) were cultured and fixed for a total of 9 glass coverslips.
Three images were collected from each glass coverslip (27
images were analyzed per timepoint per marker across all three
experiments). For Ca2+ imaging 3 glass coverslips were recorded
from 3 separate experiments. During analysis, waveforms from 5
to 10 ROI (cell somata) were decomposed as described above.
Data are presented as means ± SEM and the statistical
differences were tested by ANOVA with Bonferroni’s Multiple
Comparison post hoc or Mann-Whitney tests where appropriate,
using GraphPad Prism 6.0 (Graphpad Software, La Jolla,
CA, United States). Statistical significance was assumed when
P < 0.05, and was indicated by an asterisk on the respective
data point in the figure. Two asterisks indicated P < 0.01 and
three P < 0.001.
RESULTS
Immunocytochemical Analysis of Mouse
Embryonic Stem Cell Line Derived
Astrocytes
The mESC induction and differentiation protocols generated
a heterogeneous population of astrocytes. The EBs formed
during the neural induction process were plated onto laminin
coated coverslips (10–20 EBs per coverslip) and were cultured
in astrocyte medium. Plated EBs attached to the surface and
projected cells to their surrounding environment. We used
a broad panel of fluorescent probes to astrocytic markers to
characterize the differentiating mESC at DIV 7, 14, 21, and 28.
The following astrocytic and purinoreceptor markers were used:
GFAP (Figures 2A–D; Eng et al., 2000), ALDH1L1 (Figures 2E–
H; Cahoy et al., 2008), S100β (Figures 2I–L; Raponi et al., 2007),
and P2Y1R (Figures 2M–P; Hamilton et al., 2008).
The number of GFAP+ cells increased over four weeks
(Figure 3A) and at DIV 14 approximately half of the cell
population was GFAP+ (Figure 3C: 52.93% ± 14.94%, n = 9)
and exhibited typical astrocytic morphology (Figure 2B). This
percentage significantly increased during the following weeks
and plateaued at DIV 28 (Figure 3C: 73.68% ± 9.03%, n = 9).
FIGURE 2 | Confocal culture micrographs (7–28 DIV) of astrocytes inducted
from mESC, immunofluorescently labeled for established astrocytic markers:
(A–D) – GFAP, (E–H) – ALDH1L1, (I–L) – S100B, and (M–P) – P2Y1R. Cell
nuclei marker H-33342 (blue stain). Scale bar 20 µm.
Assessment of the relative surface area covered by GFAP+ cells
revealed a statistically significant increase (p < 0.05) from less
than 5% surface coverage at DIV7 (Figure 3B: 3.88% ± 1.060%,
n = 9) to more than 40% at DIV28 (Figure 3B: 44.23%± 5.268%,
n = 9). We also calculated the area covered by the average
individual GFAP+ cell at different DIV (Figure 3D). We found
a significant (p < 0.05) doubling in GFAP+ cell size from DIV
7 (Figure 3D: 0.054% ± 0.0057%, n = 9) to DIV28 (Figure 3D:
0.284% ± 0.088%, n = 9), which coincided with a shift from
a “dinner plate” (Molofsky and Deneen, 2015) morphology at
DIV 7 (Figure 2A) to an enlarged, complex morphology with
elongated processes (typically seen in primary astrocytes) at
DIV 28 (Figure 2D).
We observed that the number and percentage of S100β+ cells
dropped significantly (P < 0.05) between DIV 7 (Figures 3I,K:
32.82%± 4.61%, n = 9) and DIV 14 (Figure 3K: 14.52%± 3.29%,
n = 9). The following 2 weeks S100β+ cells recovered and
plateaued at DIV 28 (Figure 3K: 25.04% ± 4.67%, n = 9).
During neural progenitor differentiation S100β is repressed and
reappears in mature astrocytic phenotypes. Its role also changes
from regulating GFAP conformation and cell proliferation
to binding calcium, and mediating inflammatory markers
(Selinfreund et al., 1991; Raponi et al., 2007). The relative surface
area covered by S100β+ cells was highest at DIV 7 (Figure 3J:
13.56% ± 1.55%, n = 9), with a statistically significant reduction
(p < 0.05) at DIV 14 (Figure 3J: 7.01% ± 1.78%, n = 9), which
coincided with the decrease in the percentage of S100β+ cells.
At DIV 21 and 28, cell coverage followed a similar trend to
the percentage of S100β+ cells. Analysis of area coverage of an
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FIGURE 3 | Quantification of astrocyte marker expression: (A–D) – GFAP, (E–H) – ALDH1L1, (I–L) – S100B. (A,E,I) absolute number of marker positive cells per
mm2. (B,F,J) Percent (%) area covered by marker positive cells. (C,G,K) Percent (%) of marker positive cells. (D,H,L) Percent of area covered by an average marker
positive cell. Data expressed as mean ± SEM from three separate experiments, ∗P < 0.05 and ∗∗P < 0.01.
average individual S100β+ cell showed no significant differences
across DIVs and was stable at approximately 0.08% (Figure 3L).
Analysis of ALDH1L1 immunolabeled cultures revealed
no significant difference in the number or percentage of
ALDH1L1+ cells from DIV 7 to DIV 28 (Figures 3E,G: stable
at approximately 40%). A non-significant upward trend was
observable on the relative surface area coverage (Figure 3F)
from DIV 7 to DIV 28, whereas relative area coverage of
an average ALDH1L1+ cell remained stable at approximately
0.07% (Figure 3H).
Pluripotency gene Nanog Homebox (Nanog) was minimally
expressed (see Supplementary Material) post DIV 7,
indicating the limited presence of stem cells amongst the
generated astrocyte population (Supplementary Figure
S1A). We did not detect any expression of the allograft
inflammatory factor 1 (iba1 present in microglia) in our
PCR screening (unpublished data) at DIV 7 or later. We
also stained but did not detect any expression of NESTIN
at DIV 7 or later (Supplementary Figure S1B), suggesting
absence or very limited presence of neural progenitors,
during the EB seeding/astrocyte induction phase of our
differentiation protocol.
Co-localization of Astrocytic Markers
Astrocytes generated in vitro are not as homogenous in
marker expression as previously assumed. To highlight the
existence of subpopulations of astrocytes, we performed double-
immunolabeling of GFAP with either ALDH1L1 (Figure 4A) or
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FIGURE 4 | Co-localization of astrocytic markers (GFAP, ALDH1L1, and S100β). (A) Culture example at DIV 21 of astrocytes co-expressing GFAP and ALDH1L1
(yellow arrow) or expressing only ALDH1L1 (white arrow). (B) Culture example at DIV 21 of astrocytes co-expressing GFAP and S100β (yellow arrow) or expressing
only S100β (white arrow). Cell nuclei marker H-33342 (blue stain). Scale bar 20 µm. (C,D) Analysis of co-localization across different days in vitro reveals
heterogeneity of differentiated astrocytes in protein expression. Pearson’s correlation coefficient of GFAP/ALDH1L1 and GFAP/S100β stains from DIV 7 to DIV 28.
S100β (Figure 4B). In the two figures the white arrows point
to cells expressing only one protein, ALDH1L1 or S100β, while
the yellow arrows point to cells expressing both proteins. These
culture micrographs from DIV 21 highlight the presence of
astrocytes at different developmental stages, as GFAP is usually
expressed in more mature astrocytes. We calculated the PCC of
the two stains and revealed that not all cells express all astrocytic
markers simultaneously, illustrating the existence of astrocytic
sub-populations. Analysis of ALDH1L1 and GFAP co-staining
revealed a positive correlation, which was increasing toward
the late time-points (Figure 4C PCC at DIV 7 0.165 ± 0.07
n = 9 and DIV 28 0.486 ± 0.04 n = 9). S100β and GFAP
stains were not correlated throughout the culture, although there
were multiple cells expressing only one or both of the markers
(Figure 4D PCC at DIV7 0.173 ± 0.06 n = 9 and DIV 28
0.104± 0.09 n = 9).
The expression of purinergic receptors was not uniform
across all GFAP+ astrocytes. P2Y1R purinoceptors expression
was evident in both GFAP+ and GFAP− populations (Figure 5A,
white and yellow arrows, respectively). The percent area
covered by P2Y1R+ did not change significantly across different
DIV (Figure 5B).
The glutamate-aspartate transporter (GLAST or EAAT1)
was also detected and was expressed predominantly in
GFAP+ astrocytes (Figure 5C, white arrow). However, we
did see examples of EAAT1+/GFAP− cells (Figure 5D,
yellow arrow).
Mouse Embryonic Stem Cell
Line-Derived Astrocytes Exhibit Ca2+
Transients Upon Adenosine Triphosphate
Stimulation
We examined whether the generated astrocytes had functionally
mature and responsive purinergic pathways (Figure 6A).
Stimulation of astrocytes via ATP (50 µM) generated slow
wave-like Ca2+ transients, a hallmark of astrocyte function
(Bazargani and Attwell, 2016; Shigetomi et al., 2016). A time-
lapse sequence of a 5 minute recording is illustrated in Figure 6A,
where calcium concentration in multiple regions of interest
(e.g., middle right and middle left) increases (from 30 to 60 s)
and returns to initial levels (from 90 to 300 s). Quantification
of the percentage of astrocytes displaying transients showed a
significant (p < 0.05) decrease in percentage of non-responsive
cells from approximately 20% at DIV 7 to approximately 5% at
DIV 28 (Figure 6B). Cellular responses to ATP stimulus were
inhibited by the broad-spectrum P2X/2Y antagonist suramin,
which blocks metabotropic (P2Y1R) and ionotropic (P2X7)
purinoceptors (Bernstein et al., 1998). Upon ATP stimulation, we
observed a stunted response in suramin treated cells (Figure 6C)
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FIGURE 5 | Double ICC staining of mESC derived astrocytes for markers GFAP, P2Y1R. (A) Culture example at DIV 21 of GFAP+ (white arrow) astrocytes and
GFAP− cells (yellow arrow) expressing the metabotropic P2Y1R receptor. (B) Quantification of P2Y1R expression: percent (%) area covered by P2Y1R+ cells.
(C) Culture example at DIV 21 of GFAP+ (white arrow) expressing the Glutamate Aspartate Transporter (GLAST, also known as EAAT1). (D) Culture example at DIV
21 of GFAP− (yellow arrow) expressing GLAST. Cell nuclei marker H-33342 (blue stain). Scale bars 20 µm.
across all time-points, providing further validation that prior
Ca2+ responses were indeed purinergic.
We decomposed the Ca2+ waveforms into three different
components: rise time (RT), area under the curve (AUC) and
decay tau (DT) (James et al., 2011). We also calculated the latency
between the application of ATP and the rise in intracellular
Ca2+ concentration (Bernstein et al., 1998). Responses exhibited
a significant reduction in AUC at DIV 21 (54.38 ± 2.56,
n = 3) and DIV 28 (62.08 ± 4.51, n = 3), compared to
DIV 7 (70.76 ± 5.11, n = 3), revealing a change in the total
amount of calcium trafficked in and out of the cell, as the
cultures develop (Figure 7A). Calcium clearance, measured via
DT, is significantly faster at DIV 21 (65.42 ± 13.56s, n = 3),
compared to DIV 7 (82.95 ± 11.16s, n = 3) and DIV 14
(80.66 ± 22.21s, n = 3) (Figure 7B). Furthermore, there was
a significant (p < 0.05) increase in RT of responses between
DIV 7 (3.75s ± 0.202s, n = 3) and DIV 28 (6.04s ± 0.56s,
n = 3) (Figure 7C). Latency remained stable at approximately 23 s
throughout (Figure 7D).
The P2Y1R, plays a prominent role in the rise time component
in Ca2+ kinetics (James and Butt, 2001). We observed significant
increases in the rise time of the Ca2+ transients, in the
generated astrocytes, at later developmental stages (DIV 21 and
28, Figure 7C). These findings may indicate an increase in the
number of P2Y and IP3 receptors in these cells, which enable
the release of further Ca2+ from the ER. Alternatively, the
increase in RT may be attributed to an evolution of the P2Y
receptor ability to respond to ATP, at late developmental stages
(Hamilton et al., 2008).
P2Y1R Is the Major Contributor to
Calcium Transients in Mouse Embryonic
Stem Cell Line-Derived Astrocytes
We used a P2Y1R selective antagonist (MRS2179) to offer further
evidence of the contribution of the metabotropic pathway to
Ca2+ transients. Preliminary data indicates that blocking of the
metabotropic receptor P2Y1R has distinct effects on astrocytic
responses to ATP in DIV 7 to DIV 28 cultures (Figure 8A).
We also inhibited PLC, which hydrolyzes the membrane
phospholipid PIP2 to form IP3. After the application of U73122,
ATP stimulation resulted in a stunted Ca2+ response (Figure 8B).
DISCUSSION
Rapid progress has been made in converting stem cells into
other types of neural cells, such as neurons, Schwann cells and
oligodendrocytes (Ban et al., 2007; Zhang K. et al., 2016).
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FIGURE 6 | Functional assessment of mESC derived astrocytes. (A) Time-lapse heat-map of activated astrocytes after stimulation (A) via adenosine triphosphate
(ATP) (50 µM). (B) Decrease in percentage of non-responsive cells after ATP stimulation, over the course of 4 weeks. (C) DIV 7-DIV 28 astrocytes treated with
suramin exhibit stunted Ca2+ responses after ATP application (red traces), compared to untreated astrocytes (blue traces), ∗P < 0.05.
However, inducting astrocytes from stem cells remains
largely an underdeveloped area and the majority of current
protocols are time consuming, lack granularity in astrocytic
subtype generation and often are not as efficient as neural
induction methods. In this study, we differentiated mouse
embryonic stem cells to produce functional astrocytes via
the combination of two altered protocols (Peljto et al., 2010;
Kuegler et al., 2012). Our method produces migrating astrocytes
after only 13 days in vitro (including EB formation and
seeding). Most established protocols require more than
80 days to generate astrocytes either from mouse (Roybon
et al., 2013) or human (Hu et al., 2010) ESCs, while only
recently astrocytes were differentiated from human induced
pluripotent stem cells in 30 days (Tcw et al., 2017). Our
astrocyte induction method is significantly accelerated,
compared to all these techniques. In addition, it does not
require sorting processes, or inflammatory stimulants (Shaltouki
et al., 2013; Tcw et al., 2017) and therefore is simpler and
easier to implement.
Developmental studies have shown that the sequence of
marker appearance during the initial, embryonic phase of
gliogenesis is ALDH1L1 > S100β > GFAP (Roybon et al.,
2013). This is supported by our data, as at DIV 7 expression
of ALDH1L1 is highest, followed by S100β and GFAP. We
also observed, a significant reduction in expression of S100β
from DIV 7 to DIV14, with a subsequent bounce at DIV 21.
We hypothesize that this expression pattern might be linked
to the developmental repression of the S100β protein, during
differentiation of NPC and the reappearance of the marker in
mature astrocytes (Patro et al., 2015).
The glutamate-aspartate transporter (GLAST or EAAT1) is a
membrane bound protein involved in the uptake of glutamate
from the synaptic cleft. It is expressed in both developing and
mature astrocytes and it is most prominent in the cerebellum,
hippocampus and forebrain (Kugler and Schleyer, 2004; Kim
et al., 2011). In our cultures, numerous GFAP+ astrocytes
expressed GLAST (EAAT1) particularly on their membrane,
where this cotransporter is bound (Figure 5C; Ryan et al., 2010;
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FIGURE 7 | Evolution of Ca2+ transient parameters in mESC derived astrocytes. (A) Area under the curve (AUC), (B) decay tau (DT), (C) rise time (RT), and (D)
latency. Statistical analysis reveals a significant increase in response RT from DIV7/14 to DIV 21 and DIV 28. Latency remains stable across different days in vitro (AU,
arbitrary units, data expressed as mean ± SEM from three separate experiments, n = 30 astrocytes, ∗P < 0.05).
Pajarillo et al., 2019). However, we did observe GLAST+ cells
that were negative for GFAP (Figure 5D), particularly in
earlier DIV. Similarly, co-stained cultures for GFAP, S100β and
ALDH1L1, revealed heterogeneous expression patterns, within
and across different developmental time-points. We identified
GFAP− cells that were ALDH1L1+/S100β+ (Figures 4A,B,
white arrows) and GFAP+ cells that were ALDH1L1+/S100β+
(Figures 4A,B, yellow arrows).
These findings align with in vitro studies that highlight
heterogeneous populations of astrocytes in neonatal primary
cell cultures (Tetsuya et al., 2006), in differentiating stem
cell cultures (Kuegler et al., 2012) and investigations that
have identified astrocytes with diverse inter- and intra-regional
characteristics within the mammalian CNS (Ben Haim and
Rowitch, 2017). We hypothesize that the derived astrocytes
in our protocol are at different stages of maturation, rather
than differentiating toward distinct developmental paths. This
would also explain the sparse co-labeling of GFAP+ and
ALDH1L+ cells in our cultures, as well as the predominance
of GFAP+/GLAST+ astrocytes at later developmental stages
(DIV 21/28). These astrocytes should be able to recycle
glutamate in neuron-astrocyte co-cultures, enabling further
investigations in this area.
Ca2+ release and uptake in astrocytes is regulated by
multiple pathways and receptors. Examples of include the
P2X1−5 (Pankratov et al., 2009), NMDA (Palygin et al., 2010),
cannabinoid receptor CB1 (Rasooli-Nejad et al., 2014) and a1-
noradrenaline receptors (Pankratov and Lalo, 2015). In this
study we focused on the purinergic receptors and in particular
the P2Y1R. The purinergic signaling system is one of the
main extracellular signaling systems that integrates neuronal-
glial and glial–glial circuits in the nervous system (Pascual
et al., 2005). ATP is the principal purinergic signaler and is
released from cells by several mechanisms, such as exocytosis,
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FIGURE 8 | Pharmacological treatment of mESC derived astrocytes isolates individual purinoceptor contributions to Ca2+ elevation. (A) Individual astrocytes from
MRS2179 treated DIV 7-DIV 28 cultures exhibit stunted Ca2+ responses after ATP application (red traces), compared to untreated astrocytes (blue traces).
(B) Pharmacological treatment of mESC derived astrocytes with phospholipase C (PLC) inhibitor, U73122. Bath incubation of DIV 28 astrocytes with U73122 results
in a stunted response upon ATP stimulation. Purple trace. ATP response after U73122 treatment; Blue trace, ATP response without U73122 treatment.
diffusion through membrane channels and transporters mediated
release. Purinergic receptors initiate numerous downstream
signaling cascades, which mediate physiological and pathological
astrocyte responses (Franke et al., 2012). We observed significant
expression of P2Y1R purinoceptors in GFAP+ and GFAP−
cells (Figure 5A). Having established receptor presence, we also
assessed purinergic responses in the derived astrocytes, as an
initial step in verifying their potential functionality, within a
cultured neural network.
Application of ATP to cultures resulted in a rapid
and transient rise in intracellular Ca2+ followed by an
exponential decay to baseline. The majority of the responses
were monophasic, although we did observe some biphasic
responses as well (containing a prolonged component during
the decay phase), particularly in the later developmental
time-points (Hashioka et al., 2014). Biphasic responses
may be due to late influx of Ca2+ from store operated
channels (SOC). Calcium clearance (Figure 7B) was
significantly faster at later DIV, which might be linked to
the developmental stage of the astrocytes. Variability in
astrocyte Ca2+ responses to ATP stimulation may also
be linked to the diverse protein expression patterns that
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we observed in the double immunostained cultures and may be
related to the maturation of these astrocytes.
Analysis of receptor specific pathways was probed by using
receptor specific inhibitors. P2Y1R is the main purinergic
receptor involved in transmission of Ca2+ waves between
astrocytes (Fam et al., 2000). When our astrocytes were treated
with MRS2179 (a P2Y1R antagonist) they exhibited significantly
reduced Ca2+ responses to ATP stimulation (Figure 8A). Similar
effects of P2Y1R inhibition by MRS2179 have been reported
in vivo studies of white matter astrocytes (Hamilton et al.,
2008). Furthermore, inhibition of the PLC pathway resulted in
a stunted Ca2+ response to ATP, signifying the involvement of
IP3 in Ca2+ elevation in our astrocytes. Our experiments provide
preliminary evidence that Ca2+ elevation in the generated
astrocytes could be a result of the metabotropic pathway, and
possibly initiated at the P2Y1R receptor. Further experiments
with selective agonists and antagonists will isolate the specific
P2Y receptor involved.
CONCLUSION
In this study, we derived functional astrocytes from Mouse
Embryonic Stem Cell Line in under 2 weeks. Currently, this
is the fastest protocol available to produce astrocytes. The
generated astrocytes respond to ATP (50 µM) stimulation
via intracellular Ca2+ concentration elevation and express
proteins associated to astrocytic development and maturation.
Differential transient responses to ATP and diverse expression
profiles for ALDH1L1, S100β, GLAST, and GFAP reveal
a heterogeneous astrocyte population, at different stages
of development (DIV 7-28). Furthermore, we provide
preliminary evidence that the metabotropic purinoceptor
P2Y1R may be the main factor in ATP induced Ca2+
activity. Due to its simplicity, reproducibility and speed,
we believe our protocol will be useful in many future
investigations, concerning the involvement of astrocytes
in neuronal synaptic development and support, and the
role of purinergic signaling in activity propagation in vitro
neural networks.
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FIGURE S1 | (A) Nanog expression levels relative to GAPDH reveal statistically
significant downregulation of the gene by DIV 28. (B) Representative culture
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of neurons and their precursors. Scale bar 20µm. ∗P < 0.05.
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